Literature DB >> 33662594

Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis.

Amit G Singal1, Yixing Chen2, Shrihari Sridhar3, Vikas Mittal4, Hannah Fullington5, Muzeeb Shaik3, Akbar K Waljee6, Jasmin Tiro7.   

Abstract

OBJECTIVE: There has been increased interest in interventions to promote hepatocellular carcinoma (HCC) surveillance given low utilization and high proportions of late stage detection. Accurate prediction of patients likely versus unlikely to respond to interventions could allow a cost-effective approach to outreach and facilitate targeting more intensive interventions to likely non-responders.
DESIGN: We conducted a secondary analysis of a randomized clinical trial evaluating a mailed outreach strategy to promote HCC surveillance among 1200 cirrhosis patients at a safety-net health system between December 2014 and March 2017. We developed regularized logistic regression (RLR) and gradient boosting machine (GBM) algorithm models to predict surveillance completion during each of the 3 screening rounds in a training set (n = 960). Model performance was assessed using multiple performance metrics in an independent test set (n = 240).
RESULTS: Among 1200 patients, surveillance was completed in 41-47% of patients over the three rounds. The RLR and GBM models demonstrated good discriminatory accuracy, with area under receiver operating characteristic (AUROC) curves of 0.67 and 0.66 respectively in the first surveillance round and improved to 0.77 by the third surveillance round after incorporating prior screening behavior as a feature. Additional performance characteristics including the Brier score, Hosmer-Lemeshow test and reliability diagrams were also evaluated. The most important variables for the predictive model were prior screening completion status and past primary care contact.
CONCLUSIONS: Predictive models can help stratify patients' likelihood to respond to surveillance outreach invitations, facilitating tailored strategies to maximize effectiveness and cost-effectiveness of HCC surveillance population health programs.
Copyright © 2022 AGA Institute. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Liver Cancer; Prediction; Screening

Mesh:

Year:  2021        PMID: 33662594      PMCID: PMC9048842          DOI: 10.1016/j.cgh.2021.02.038

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  34 in total

1.  Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.

Authors:  Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

2.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

3.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

4.  Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.

Authors:  David E Kaplan; Feng Dai; Ayse Aytaman; Michelle Baytarian; Rena Fox; Kristel Hunt; Astrid Knott; Marcos Pedrosa; Christine Pocha; Rajni Mehta; Mona Duggal; Melissa Skanderson; Adriana Valderrama; Tamar H Taddei
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

5.  Use of administrative claims data for identifying patients with cirrhosis.

Authors:  Mahendra S Nehra; Ying Ma; Christopher Clark; Ruben Amarasingham; Don C Rockey; Amit G Singal
Journal:  J Clin Gastroenterol       Date:  2013 May-Jun       Impact factor: 3.062

6.  Projections of primary liver cancer to 2030 in 30 countries worldwide.

Authors:  Patricia C Valery; Mathieu Laversanne; Paul J Clark; Jessica L Petrick; Katherine A McGlynn; Freddie Bray
Journal:  Hepatology       Date:  2017-12-23       Impact factor: 17.425

7.  Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Eimile Dalton-Fitzgerald; Jasmin Tiro; Pragathi Kandunoori; Ethan A Halm; Adam Yopp; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-11       Impact factor: 11.382

8.  Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.

Authors:  Christopher D Jensen; Douglas A Corley; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Amy R Marks; Joanne E Schottinger; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Carrie N Klabunde; Charles P Quesenberry; Theodore R Levin; Pauline A Mysliwiec
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391

9.  Testing Interventions to Motivate and Educate (TIME): A multi-level intervention to improve colorectal cancer screening.

Authors:  Jessica L Krok-Schoen; Gregory S Young; Michael L Pennell; Paul L Reiter; Mira L Katz; Douglas M Post; Cathy M Tatum; Electra D Paskett
Journal:  Prev Med Rep       Date:  2015-01-01

10.  Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Authors:  Amit G Singal; Anjana Pillai; Jasmin Tiro
Journal:  PLoS Med       Date:  2014-04-01       Impact factor: 11.069

View more
  3 in total

1.  MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.

Authors:  Yilang Wang; Xiaohong Chen; Ninghua Yao; Jun Gong; Yongfeng Cao; Xiaoqing Su; Xiu Feng; Min Tao
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.

Authors:  Amit G Singal; Sarah Reddy; Himani Radadiya Aka Patel; Deyaun Villarreal; Aisha Khan; Yan Liu; Vanessa Cerda; Nicole E Rich; Caitlin C Murphy; Jasmin A Tiro; Jennifer R Kramer; Ruben Hernaez
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-10       Impact factor: 13.576

3.  Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.

Authors:  Neehar D Parikh; Nabihah Tayob; Taim Al-Jarrah; Jennifer Kramer; Jennifer Melcher; Donna Smith; Patrick Marquardt; Po-Hong Liu; Runlong Tang; Fasiha Kanwal; Amit G Singal
Journal:  JAMA Netw Open       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.